Device / Technology News

RSS

Potential new early cancer detection method using engineered gold nanoparticles

University of Missouri School of Medicine scientists explain a potentially new early cancer detection and treatment method using nanoparticles created at MU in an article published in the Proceedings of the National Academy of Sciences. The article illustrates how engineered gold nanoparticles tied to a cancer-specific receptor could be targeted to tumor cells to treat prostate, breast or lung cancers in humans.

23 Apr 2010

CAPS launches new service for admixture and delivery of Hibernation Therapeutics' Adenocaine microplegia

Central Admixture Pharmacy Services, Inc. (CAPS®), a B. Braun company, announced today the launch of its newest service for the admixture and delivery of Hibernation Therapeutics' patented Adenocaine™ microplegia, the world's first low-potassium, non-depolarizing cardioplegia solution.

From B. Braun Melsungen AG 23 Apr 2010

World's smallest and lightest microscope for telemedicine applications

Aydogan Ozcan, whose invention of a novel lensless imaging technology for use in telemedicine could radically transform global health care, has now taken his work a step further ― or tinier: The UCLA engineer has created a miniature microscope, the world's smallest and lightest for telemedicine applications.

23 Apr 2010

Detroit-area resident pleads guilty in fraudulent medical testing scheme

Detroit-area resident Melvin Young pleaded guilty today to engaging in a fraudulent medical testing scheme, announced the Departments of Justice and Health and Human Services (HHS).

23 Apr 2010

Better diagnostics in prostate cancer needed

A flurry of confusing research about the benefits of PSA testing has left many men and their physicians reticent to use a test that may be life-saving, says a panel of prostate cancer experts. The experts who gathered on Capitol Hill in Washington on Tuesday agreed that PSA testing, while not cancer-specific, is one of the best available tools for early detection of a cancer that kills 27,000 American men each year.

23 Apr 2010

Researchers use electronic medical records for injury management and surveillance during marathon

Henry Ford Hospital researchers have brought the use of electronic medical records out of the hospital setting and into the streets by using the technology for a marathon.

23 Apr 2010

BSD-2000 Hyperthermia System combined with chemotherapy promising for children with high-risk tumors

BSD Medical Corporation today reported clinical study data showing that hyperthermia, using the BSD-2000 Hyperthermia System, combined with chemotherapy has the potential to improve control rate and long-term survival for the treatment of children with high-risk cancer who have a dismal prognosis.

23 Apr 2010

TUM scientists collaborate with Fujitsu Laboratories of Japan to commercialize biosensor chip

In the battle against cancer and other diseases, precise analysis of specific proteins can point the way toward targeted treatments. Scientists at theTechnische Universitaet Muenchen, together with Fujitsu Laboratories of Japan, have developed a novel biosensor chip that not only recognizes proteins that are characteristic for specific diseases, but also can show if these proteins are changed through the influence of disease or drugs.

23 Apr 2010

Tryton Medical widens European availability of Side Branch Stent System

Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced the launch of the TRYTON Side Branch Stent™ System in Austria, Belgium, Denmark, Ireland, Luxembourg, the Netherlands, Norway, Poland, Portugal, Spain, and the United Kingdom. The stent is used to treat bifurcation lesions, the largest unmet need confronting interventional cardiology.

23 Apr 2010

Gelesis presents Attiva data at AACE 19th Annual Meeting & Clinical Congress

Boston-based medical technology firm Gelesis, Inc. unveiled its capsulated device Attiva™, and presented data showing that Attiva™ significantly increased the post-meal feeling of satiety and reduced hunger between meals in obese patients. This data was presented today at the American Association of Clinical Endocrinologists (AACE) 19th Annual Meeting & Clinical Congress.

23 Apr 2010

Cisco uses telemedicine in Southern Calif. and Southwest to lower costs

Cisco is using its HealthPresence telemedicine system in new programs in Southern California and the Southwest to "compete with other major tech companies, including Intel, IBM and General Electric, in the growing market for health-care products and services," The San Jose Mercury News/The (Raleigh, N.C.) News & Observer reports.

23 Apr 2010

NeoStem signs Collaborative Research Agreement with ImmuneRegen BioSciences

NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China and ImmuneRegen BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc., announced today that they have entered into a Collaborative Research Agreement, focused on the development of an advanced, adult human stem cell product.

23 Apr 2010

FDA grants conditional approval for first approved Total Spine Arthroplasty system clinical study

Flexuspine, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted conditional approval to begin the initial phase of the Investigational Device Exemption (IDE) for a feasibility study of its FSU device. This is the first approved clinical study for a Total Spine Arthroplasty system in the U.S.

23 Apr 2010

Cytori announces launch of PureGraft 250 fat grafting technology at ASAPS meeting

Cytori announces the product launch of PureGraft 250, a revolutionary fat grafting technology that standardizes the graft preparation process for use in aesthetic body contouring at the American Society of Aesthetic Plastic Surgeons meeting.

23 Apr 2010

Boston Scientific introduces new Kinetix Guidewire for use in PCI procedures

Boston Scientific Corporation today announced the launch of its new Kinetix™ Guidewire for use in percutaneous coronary intervention (PCI) procedures. Guidewires are small flexible wires physicians use to deliver interventional devices such as drug-eluting stents. The Kinetix Guidewire features a unique micro-cut nitinol sleeve designed for significantly improved torque control compared to conventional spring coil guidewires.

23 Apr 2010

Website launched to track aid to Haiti from 'pledge to impact'

Agence France-Presse reports that the U.N. has launched "a new website to track the estimated 9.9 billion dollars in aid pledged to Haiti by the international community in the wake of a devastating January 12 earthquake." The website is a joint project of the Haitian government and the U.N. Development Programme.

23 Apr 2010

Align Technology reports 28.5% increase year-over-year in first-quarter revenues

Align Technology, Inc. today reported financial results for the first quarter of fiscal 2010, ended March 31, 2010.

22 Apr 2010

Mystic Pharmaceuticals granted U.S. patent covering VRx2 drug delivery platform technology

Mystic Pharmaceuticals today announced it has been granted U.S. Patent 7,669,597, a key technology of its VRx2™ drug delivery platform. The VRx2™ Delivery Platform provides preservative free, precision dose delivery for ophthalmic and intranasal drugs and biologics.

22 Apr 2010

Baxter International's global sales for first-quarter advances by 11% to $3.1 billion

Baxter International Inc. today reported first quarter net income of $525 million, an increase of 2 percent from $516 million reported in the first quarter of 2009. Earnings per diluted share of $0.86 increased 4 percent from $0.83 per diluted share reported in the prior-year period. Baxter's first quarter financial results included a one-time, non-cash special charge of $39 million (or $0.07 per diluted share) related to a change in the tax treatment of post-retirement prescription drug benefits under recent U.S. healthcare reform legislation.

From Baxter International Inc. 22 Apr 2010

New gene therapy to restore retinal cone function and day vision

Veterinary ophthalmology researchers from the University of Pennsylvania have used gene therapy to restore retinal cone function and day vision in two canine models of congenital achromatopsia, also called rod monochromacy or total color blindness.

22 Apr 2010

Device / Technology News

Potential new early cancer detection method using engineered gold nanoparticles

CAPS launches new service for admixture and delivery of Hibernation Therapeutics' Adenocaine microplegia

World's smallest and lightest microscope for telemedicine applications

Detroit-area resident pleads guilty in fraudulent medical testing scheme

Better diagnostics in prostate cancer needed

Researchers use electronic medical records for injury management and surveillance during marathon

BSD-2000 Hyperthermia System combined with chemotherapy promising for children with high-risk tumors

TUM scientists collaborate with Fujitsu Laboratories of Japan to commercialize biosensor chip

Tryton Medical widens European availability of Side Branch Stent System

Gelesis presents Attiva data at AACE 19th Annual Meeting & Clinical Congress

Cisco uses telemedicine in Southern Calif. and Southwest to lower costs

NeoStem signs Collaborative Research Agreement with ImmuneRegen BioSciences

FDA grants conditional approval for first approved Total Spine Arthroplasty system clinical study

Cytori announces launch of PureGraft 250 fat grafting technology at ASAPS meeting

Boston Scientific introduces new Kinetix Guidewire for use in PCI procedures

Website launched to track aid to Haiti from 'pledge to impact'

Align Technology reports 28.5% increase year-over-year in first-quarter revenues

Mystic Pharmaceuticals granted U.S. patent covering VRx2 drug delivery platform technology

Baxter International's global sales for first-quarter advances by 11% to $3.1 billion

New gene therapy to restore retinal cone function and day vision

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Latest News